Clinical Trial Update: Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a four-drug combination (rituximab, lenalidomide, methotrexate, and temozolomide) for primary central nervous system lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)
• METHOTREXATE (METHOTREXATE)
• Rituximab (Rituxan) (rituximab)
• Temozolomide (Temodar) (Temozolomide)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Primary Central Nervous System Lymphoma | Phase 2 | Status: RECRUITING